Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register
      S&P 500
      4,320.06
      (
      -0.23%
      )
      US Tech 100
      14,316.40
      (
      0.0%
      )
      Dow Jones
      33,963.84
      (
      -0.31%
      )
      Brent Oil
      92.625
      (
      0.15%
      )
      Bitcoin
      26,107.21
      (
      -0.56%
      )
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Emergent Biosolutions Inc (EBS)

      7. Emergent Biosolutions Inc (EBS) News

      EBS Emergent Biosolutions Inc

      3.26
      0.00 (0.0%)
      Sep 24 2023 - Closed
      Delayed by 15 minutes

      Register Free for Streaming Quotes & Tools

      Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.

      Register
      Company Name Stock Ticker Symbol Market Type
      Emergent Biosolutions Inc EBS NYSE Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.0% 3.26 20:00:00
      Open Price Low Price High Price Close Price Prev Close
      3.26
      more quote information »

      Recent News

      Date Time Source Heading
      8/30/202306:30EDGAR2Form 8-K - Current report
      8/30/202305:59GLOBEEmergent BioSolutions’ NARCAN® Nasal Spray Launches Over the..
      8/21/202318:01PRNUSKenvue Set to Join S&P 500; Advance Auto Parts to Join S&P..
      8/16/202316:47EDGAR2Form 8-K - Current report
      8/15/202312:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
      8/09/202307:15IHMARKETNEWSWednesday’s Wall Street Highlights: Amazon, Disney, Upstart,..
      8/08/202316:31GLOBEEmergent BioSolutions Reports Financial Results for Second..
      8/08/202316:12EDGAR2Form 8-K - Current report
      8/08/202307:15EDGAR2Form 8-K - Current report
      8/08/202307:15GLOBEEmergent BioSolutions Announces Strategic Steps to..
      7/31/202317:04DJNEmergent BioSolutions Gets $704 Million Ebola Treatment..
      7/31/202316:26EDGAR2Form 8-K - Current report
      7/31/202316:05GLOBEEmergent BioSolutions Awarded 10-Year BARDA Contract Valued..
      7/27/202316:48EDGAR2Form 8-K - Current report
      7/25/202306:30GLOBEEmergent BioSolutions to Release Second Quarter 2023..
      7/24/202308:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/24/202308:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      7/21/202308:25EDGAR2Form 8-K - Current report
      7/21/202307:14DJNEmergent BioSolutions Shares Rise 16% After Cyfendus..
      7/20/202318:03GLOBEEmergent BioSolutions Receives U.S. FDA Approval of..
      6/27/202307:55GLOBEEmergent BioSolutions Announces CEO Transition
      5/15/202307:58GLOBEEmergent BioSolutions Finalizes Sale of Travel Health..
      5/11/202306:30GLOBEEmergent BioSolutions to Hold Virtual Annual Meeting of..
      5/09/202316:05GLOBEEmergent BioSolutions Reports Financial Results For First..
      4/19/202316:05GLOBEEmergent BioSolutions to Release First Quarter 2023..
      3/29/202309:48GLOBEU.S. FDA Approves Over-the-Counter Designation for Emergent..
      3/29/202309:39DJNEmergent BioSolutions Stock Rises 17% on FDA Narcan Approval
      2/27/202316:42GLOBEEmergent BioSolutions Reports Financial Results for Fourth..
      2/15/202318:22DJNEmergent Bio Shares Up 14% as FDA Panel OKs OTC Narcan Nasal..
      2/15/202317:19GLOBEEmergent BioSolutions Reports FDA Advisory Committees’..
      2/15/202302:00GLOBEEmergent BioSolutions Announces Sale of Travel Health..
      2/06/202316:05GLOBEEmergent BioSolutions to Release Fourth Quarter 2022..
      1/09/202306:59GLOBEEmergent BioSolutions Announces Organizational Changes as..
      1/05/202317:30GLOBEEmergent BioSolutions Awarded $379.6 Million Procurement..
      12/06/202206:00GLOBEEmergent BioSolutions Announces U.S. FDA Acceptance and..
      11/14/202206:30GLOBEEmergent BioSolutions Receives Department of Defense Award..
      11/08/202216:16GLOBEEmergent BioSolutions Reports Financial Results For Third..
      11/01/202216:05GLOBEEmergent BioSolutions Presents Data from Phase 2 Study..
      10/27/202208:30GLOBESAB Biotherapeutics Announces Exclusive Manufacturing..
      10/18/202206:30GLOBEEmergent BioSolutions to Release Third Quarter 2022..
      9/26/202216:12GLOBEEmergent BioSolutions Completes Acquisition of Exclusive..